This article has been updated to reflect that Orig3n did not acquire Interleukin's heart health test, which was previously sold. A press release announcing the acquisition inaccurately mentioned the test, according to an Orig3n spokesperson

NEW YORK (GenomeWeb) – Orig3n announced today that it has acquired Interleukin Genetics' CLIA-certified laboratory and its remaining assets.

Financial terms of the deal were not disclosed.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.